Cover Image
市場調查報告書

全球POC診斷市場預測 (2017∼2027年):各產品 (血糖,感染疾病,迅速凝固,迅速心臟標記,膽固醇,妊娠,其他) 收益預測,主要企業評估附著主要國家市場

POC Diagnostics Market Forecast 2017-2027: Revenue Prospects By Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies

出版商 Visiongain Ltd 商品編碼 299052
出版日期 內容資訊 英文 289 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球POC診斷市場預測 (2017∼2027年):各產品 (血糖,感染疾病,迅速凝固,迅速心臟標記,膽固醇,妊娠,其他) 收益預測,主要企業評估附著主要國家市場 POC Diagnostics Market Forecast 2017-2027: Revenue Prospects By Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies
出版日期: 2017年09月12日 內容資訊: 英文 289 Pages
簡介

全球POC診斷市場,預計2017年超越50億美元。該市場預計至2027年收益大幅成長。

本報告提供全球POC診斷市場相關調查,今後的收益預測,各產品,各地區趨勢,及加入此市場的以及主要企業的簡介等彙整。

第1章 本報告概要

第2章 體外診斷及POC診斷的簡介

第3章 體外診斷市場

  • 各分類市場
  • 銷售額預測
  • 臨床診斷市場
  • POC診斷市場

第4章 POC診斷市場

  • 市場概要
  • 市場區隔
  • 各產品市場
    • 市場概要
    • 市場預測
    • 各產品市場佔有率
    • 血糖檢驗
    • 傳染病檢查
    • 迅速血液凝固檢驗
    • 迅速心臟標記檢驗
    • 膽固醇檢驗
    • 妊娠檢驗
    • 其他

第5章 POC血糖檢驗市場

  • 市場概要
  • 全球市場
  • 市場預測
  • 促進因素與阻礙因素

第6章 POC血液凝固檢驗市場

第7章 心臟標記市場

第8章 POC傳染病檢查市場

第9章 POC妊娠檢驗市場

第10章 POC膽固醇檢驗市場

第11章 主要國家市場

  • 到2027年的市場佔有率的變動
  • 美國市場
  • 歐洲主要國家
  • 日本
  • 金磚四國
  • 其他

第12章 主要企業

  • F. Hoffmann-La Roche AG
  • Abbott
  • Siemens Healthineers
  • Alere Inc.

第13章 定性分析

  • 簡介
  • 促進因素與阻礙因素
  • PESTEL分析
  • POC診斷市場
  • SWOT分析

第14章 結論

第15章 用語

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0235

POC Diagnostics - our new study reveals trends, R&D progress, and predicted revenues

Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.

POC Diagnostics, by Product Type

  • Blood Glucose
  • Infectious Diseases
  • Rapid Coagulation
  • Rapid Cardiac Marker
  • Cholesterol
  • Pregnancy
  • Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets:

  • The US
  • Germany
  • The UK
  • Italy
  • Spain
  • France
  • Switzerland
  • Belgium
  • The Netherlands
  • Japan
  • China
  • India
  • Brazil
  • Russia
  • South Africa
  • RoW

image1

The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the POC Diagnostics Market report helps you

In summary, our 289-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 15 key national markets - See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 4 of the major companies involved in the POC Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global POC Diagnostics Market Overview
  • 1.2 Global POC Diagnostics Market Segmentation
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Who is This Report For?
  • 1.9 Methodology
  • 1.10 Frequently Asked Questions (FAQ)
  • 1.11 Associated Visiongain Reports
  • 1.12 About Visiongain

2. Introduction to In Vitro and POC Diagnostics

  • 2.1 An Introduction to In Vitro Diagnostics
  • 2.2 Classifying In Vitro Diagnostics
    • 2.2.1 FDA Classifications
    • 2.2.2 IVD Classifications in Australia
    • 2.2.3 EDMA Classification
      • 2.2.3.1 Clinical Chemistry
      • 2.2.3.2 Immunochemistry
      • 2.2.3.3 Haematology
      • 2.2.3.4 Microbiology
      • 2.2.3.5 Genetic Testing
      • 2.2.3.6 Point Of Care Diagnostics: The Dominating Segment
  • 2.3 Diagnostics Regulation of the IVD and POC Market
    • 2.3.1 FDA and CLIA Regulation of IVD and POC Tests
    • 2.3.2 Regulation of IVD/POC Diagnostics in the EU: The EC (European Commission) Classification
  • 2.4 Regulation for In Vitro Diagnostics and POC Diagnostics
    • 2.4.1 Top Ten Challenges in Regulation for In-Vitro Diagnostics
    • 2.4.2 Device Excise Tax: A Threat to the Diagnostics Manufacturers
  • 2.5 Uses of Point of Care (POC) Diagnostics
  • 2.6 Advantages and Disadvantages of POC Diagnostics

3. The In Vitro Diagnostics Market, 2016

  • 3.1 The Global In Vitro Diagnostics by Segment, 2016
  • 3.2 The Global In Vitro Diagnostics Market Sales Forecast, 2016-2027
    • 3.2.1 POC Diagnostics to Drive the Global IVD Market in the Next 10 Years
  • 3.3 The Global Clinical Diagnostics Market Forecast, 2017-2027
  • 3.4 The Global Point of Care Diagnostics Market: Sales Forecast 2017-2027
    • 3.4.1 The Drive of Personalised Medicine

4. The Global Point of Care Diagnostics Market, 2016-2027

  • 4.1 Market Overview, 2016
    • 4.1.1 Self-testing Constituted the Largest Segment in the POC Market by the Point of Delivery
  • 4.2 Point of Care Diagnostics Market Segmentation
  • 4.3 POC Diagnostics Market, by Product 2017-2027
    • 4.3.1 Market Overview, 2016
      • 4.3.1.1 Scope of the Point of Care Diagnostics Market
      • 4.3.1.2 Which Point of Care Diagnostic Segment Holds the Greatest Potential?
    • 4.3.2 Market Forecast 2017-2027
    • 4.3.3 Market Share of POC Diagnostics by Product
    • 4.3.4 Blood Glucose Testing: Market Forecast, 2016-2027
    • 4.3.5 Infectious Diseases Testing: Market Forecast, 2016-2027
    • 4.3.6 Rapid Coagulation Testing: Market Forecast, 2016-2027
    • 4.3.7 Rapid Cardiac Marker Testing: Market Forecast, 2016-2027
    • 4.3.8 Cholesterol Testing: Market Forecast, 2016-2027
    • 4.3.9 Pregnancy Testing: Market Forecast, 2016-2027
    • 4.3.10 Other Testing: Market Forecast, 2016-2027
      • 4.3.10.1 Cancer Diagnostics To Fuel Market Growth
      • 4.3.10.2 The Haematology Market Will Be Driven by Blood Gas Tests
      • 4.3.10.3 A Recently Discovered Biomarker for Sepsis Can Set The Potential For A Future Rapid Blood Test
      • 4.3.10.4 Successful Clinical Study of Quo-Test A1c POCT Analyser For Diabetes Screening

5. Global POC Blood Glucose Testing Market, 2017-2027

  • 5.1 Market Overview, 2016
  • 5.2 Global POC Blood Glucose Testing Market, 2016
  • 5.3 POC Blood Glucose Testing Market Forecast, 2016-2027
    • 5.3.1 POC Blood Glucose Testing Market, By Type of Meter
    • 5.3.2 POC Blood Glucose Testing Market, By Type of Meter
      • 5.3.2.1 POC Blood Glucose Testing Devices Currently Available in the Market, 2016
    • 5.3.3 Leading Regional Markets in the POC Blood Glucose Testing Market, 2016
    • 5.3.4 Leading Companies in the POC Blood Glucose Testing Market, 2016
      • 5.3.4.1 Other Companies in the POC Blood Glucose Testing Market: Recent Advances
    • 5.3.5 Market Prospects to 2027: Which Product Will Lead the Market?
      • 5.3.5.1 Advantages and Disadvantages of the Current CGM Tests in the Market
  • 5.4 Drivers and Restraints for the POC Blood Glucose Testing Market, 2017-2027

6. Global POC Coagulation Testing Market, 2017-2027

  • 6.1 Market Overview, 2016
  • 6.2 Global POC Coagulation Testing Market in 2016
    • 6.2.1 PT/INR Monitoring is the Largest Segment in the POC Coagulation Testing Market
  • 6.3 Products Available in the POC Coagulation Testing Market, 2016
    • 6.3.1 Patient Self-Testing is the Fastest Growing Segment
  • 6.4 POC Coagulation Testing Market Segment by Components
    • 6.4.1 Test Strips Generate 85.8% of the Sales in the PT/INR POC Testing Market
  • 6.5 POC Coagulation Testing Market by Type of Drug
    • 6.5.1 Anticoagulants
    • 6.5.2 Heparins
    • 6.5.3 Vitamin K Antagonists
    • 6.5.4 Direct Thrombin Inhibitors
    • 6.5.5 Direct Factor Xa Inhibitors
  • 6.6 The POC Coagulation Testing Market by Regions, 2016
  • 6.7 POC Coagulation Testing Market Forecast 2016-2027
  • 6.8 Leading Companies in the POC Coagulation Testing Market, 2016
    • 6.8.1 Roche Dominated the POC Coagulation Testing Market with CoaguChek XS System in 2016
    • 6.8.2 Market Prospects to 2027: Who Will Be The Leading Product?
  • 6.9 Drivers and Restraints for the POC Coagulation Testing Market, 2017-2027

7. Global Cardiac Marker Diagnostic Testing Market, 2017-2027

  • 7.1 Market Overview, 2016
  • 7.2 The Global Cardiac Marker Diagnostic Testing Market 2016
  • 7.3 Cardiac Marker Diagnostic Testing Market Forecast 2017-2027
    • 7.3.1 Leading Regional Markets in the Cardiac Marker Diagnostic Testing, 2016
    • 7.3.2 Leading Companies in the Cardiac Marker Diagnostic Testing Market, 2016
    • 7.3.3 Cardiac Marker Diagnostic Testing Market: Leading Products
    • 7.3.4 Which Company is Dominating the Market?
    • 7.3.5 A Leading Product: Abbott's i-STAT
  • 7.4 Drivers and Restraints for the Cardiac Marker Diagnostic Testing Market, 2017-2027
    • 7.4.1 Challenges for the New Entrants in the Cardiac Markers Diagnostic Testing Market

8. Global POC Infectious Diseases Testing Market, 2017-2027

  • 8.1 Market Overview, 2016
  • 8.2 Global POC Infectious Diseases Testing Market, 2016
    • 8.2.1 Breakdown of the POC Infectious Diseases Testing Market by Diseases, 2016
      • 8.2.1.1 Influenza/Flu
      • 8.2.1.2 HIV
      • 8.2.1.3 Hepatitis
      • 8.2.1.4 Tuberculosis
      • 8.2.1.5 Sexually Transmitted Diseases
  • 8.3 The POC Infectious Diseases Testing Market: Leading Products 2016
    • 8.3.1 HIV Leading POC Diagnostics Products, 2016
      • 8.3.1.1 HIV Diagnostics Kits Approved by the FDA, 2016
      • 8.3.1.2 HIV POC Tests Pipeline, 2016
      • 8.3.1.3 Driving Factors for Growth of HIV Rapid Testing: Past and Future
    • 8.3.2 The Hepatitis POC Testing Market
      • 8.3.2.1 First Rapid HCV Test Approved in the US
      • 8.3.2.2 Driving Factors for Growth of Hepatitis Rapid Testing
    • 8.3.3 The Influenza POC Testing Market and Leading Companies, 2016
  • 8.4 POC Diagnostics Infectious Diseases Recent Trends
    • 8.4.1 OraQuick Marker, OraSure Technologies: First OTC Home-Use Rapid HIV Test Approved by the FDA
    • 8.4.2 Determine HIV-1/2 Ag/Ab Combo Test, Alere: First Rapid Diagnostic Test to Detect Both HIV-1 Antigen And HIV-1/2 Antibodies
  • 8.5 Leading Regional Markets in the POC Infectious Diseases Testing
    • 8.5.1 Infectious Diseases POC Testing: Regional Markets in 2016
  • 8.6 Infectious Diseases POC Testing Market: Leading Companies 2016
  • 8.7 The POC Infectious Diseases Testing Market Forecast, 2017-2027
  • 8.8 Drivers and Restraints for the POC Infectious Diseases Testing Market, 2017-2027

9. Global POC Pregnancy Testing Market, 2017-2027

  • 9.1 Market Overview, 2016
  • 9.2 Global POC Pregnancy Testing Market, 2016
  • 9.3 The POC Pregnancy Testing Market Forecast 2017-2027
    • 9.3.1 The POC Pregnancy Testing Market: Leading Products 2016
    • 9.3.2 Leading Companies in the POC Pregnancy Testing Market, 2016
  • 9.4 Drivers and Restraints for the POC Pregnancy Testing Market, 2016-2027

10. Global POC Cholesterol Testing Market, 2017-2027

  • 10.1 Market Overview, 2016
  • 10.2 The Global POC Cholesterol Testing Market in 2016
  • 10.3 The POC Cholesterol Testing Market Forecast 2017-2027
    • 10.3.1 POC Cholesterol Testing Biomarkers: Overview
    • 10.3.2 The POC Cholesterol Testing Market by Components
    • 10.3.3 Recent Developments in the POC Cholesterol Testing Market, 2016
    • 10.3.3.1 Roche's Accutrend Plus
    • 10.3.4 POC Cholesterol Testing Market: Considerations in Production
  • 10.4 Drivers and Restraints for the POC Cholesterol Testing Market, 2016-2027

11. Leading National Markets 2017-2027

  • 11.1 Geographical Breakdown of the World POC Diagnostics Market
  • 11.2 Global POC Diagnostics Market: Regional Forecast 2017-2027
  • 11.3 How Will Regional Market Shares Change to 2027?
  • 11.4 The U.S. POC Diagnostics Market 2017-2027
    • 11.4.1 Healthcare Expending in the US
    • 11.4.2 The US POC Diagnostics Market Dynamics: Drivers and Restraints
    • 11.4.3 The U.S. POC Diagnostics Market Forecast 2017-2027
  • 11.5 The Leading European POC Diagnostics Market 2017-2027
    • 11.5.1 German POC Diagnostics Market Forecast 2017-2027
    • 11.5.2 UK POC Diagnostics Market Forecast 2017-2027
    • 11.5.3 French POC Diagnostics Market Forecast 2017-2027
    • 11.5.4 Spanish POC Diagnostics Market Forecast 2017-2027
    • 11.5.5 Italian POC Diagnostics Market Forecast 2017-2027
    • 11.5.6 The Netherlands POC Diagnostics Market Forecast 2017-2027
    • 11.5.7 Belgian POC Diagnostics Market Forecast 2017-2027
    • 11.5.8 Swiss POC Diagnostics Market Forecast 2017-2027
  • 11.6 The Japanese POC Diagnostics Market 2017-2027
    • 11.6.1 The Japanese POC Diagnostics Market Forecast 2017-2027
  • 11.7 The BRICS Nations POC Diagnostics Market 2017-2027
    • 11.7.1 The Chinese POC Diagnostics Market 2017-2027
      • 11.7.1.1 The Chinese POC Diagnostics Market Forecast 2017-2027
    • 11.7.2 The Indian POC Diagnostics Market 2017-2027
      • 11.7.2.1 The Indian POC Diagnostics Market Forecast 2017-2027
    • 11.7.3 The Brazilian POC Diagnostics Market 2017-2027
      • 11.7.3.1 The Brazilian POC Diagnostics Market Forecast 2017-2027
    • 11.7.4 The Russian POC Diagnostics Market 2017-2027
      • 11.7.4.1 The Russian POC Diagnostics Market Forecast 2017-2027
    • 11.7.5 The South African POC Diagnostics Market 2017-2027
      • 11.7.5.1 The South African POC Diagnostics Market Forecast 2017-2027
  • 11.8 The Rest of the World POC Diagnostics Market 2017-2027
    • 11.8.1 The RoW POC Diagnostics Market Forecast 2017-2027
  • 11.9 Further Insights: Point of Care Diagnostics Approach for Developing Countries

12. Leading Companies in the POC Diagnostics Market

  • 12.1 F. Hoffmann-La Roche AG
    • 12.1.1 Global Presence
    • 12.1.2 Roche: POC Diagnostics Product Portfolio
    • 12.1.3 Roche: Planned Key Product Launches, 2017
    • 12.1.4 Roche: POC Diagnostics Financial Overview
    • 12.1.5 Roche: POC Diagnostics Recent Developments
  • 12.2 Abbott
    • 12.2.1 Abbott: POC Diagnostics Product Portfolio
    • 12.2.2 Abbott: POC Diagnostics Financial Overview
    • 12.2.3 Abbott: POC Diagnostics Recent Developments
  • 12.3 Siemens Healthineers
    • 12.3.1 Siemens Healthineers: POC Diagnostics Product Portfolio
    • 12.3.2 Siemens Healthineers: POC Diagnostics Financial Overview
    • 12.3.3 Siemens Healthineers: POC Diagnostics Recent Developments
  • 12.4 Alere Inc.
    • 12.4.1 Alere Inc.: POC Diagnostics Product Portfolio
    • 12.4.2 Alere Inc.: Financial Overview
    • 12.4.3 Alere Inc.: POC Diagnostics Recent Developments

13. POC Diagnostics Market, Qualitative Analysis, 2017-2027

  • 13.1 Introduction
  • 13.2 Drivers and Restraints for the POC Diagnostics Market
    • 13.2.1 Commercial Drivers
    • 13.2.2 Commercial Restraints
  • 13.3 PESTEL Analysis
    • 13.3.1 Political Factors
    • 13.3.2 Economic Factors
    • 13.3.3 Socio-Cultural Factors
    • 13.3.4 Technological Factors
    • 13.3.5 Environmental Factors
    • 13.3.6 Legal Factors
  • 13.4 POC Diagnostics Market: Porters Five Forces Analysis, 2017-2027
    • 13.4.1 Bargaining Power of Supplier
    • 13.4.2 Bargaining Power of Buyer
    • 13.4.3 Competitive Rivalry
    • 13.4.4 Threat of New Entrants
    • 13.4.5 Threat of Substitutes
  • 13.5 POC Diagnostics Market: SWOT Analysis, 2017-2027
    • 13.5.1 Strengths
      • 13.5.1.1 Aids in rapid medical intervention
    • 13.5.2 Weaknesses
      • 13.5.2.1 Awaiting Reimbursement Options
    • 13.5.3 Opportunities
      • 13.5.3.1 Expanding population base
    • 13.5.4 Threats
      • 13.5.4.1 Unmet Needs in Low-Middle Income Countries

14. Conclusions

  • 14.1 The World POC Diagnostics Market in 2016 and 2017
  • 14.2 Current Leading POC Diagnostics Segments
  • 14.3 Leading POC Diagnostics Companies
  • 14.4 Leading Regional Markets
  • 14.5 World POC Diagnostics Market Forecast 2017-2027
  • 14.6 The Future of the POC Diagnostics Market

15. Glossary

  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1 Global POC Diagnostics Market Segmentation Overview, 2016
  • Figure 3.1 Global IVD Market Share (%) by Segment, 2016
  • Figure 3.2 Global IVD Market Revenues ($bn) for Clinical Diagnostics and POC Diagnostics Segments, 2016
  • Figure 3.3 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 3.4 The IVD Diagnostics Market Forecast: Revenue ($bn), by Segments, 2016-2027
  • Figure 3.5 The Clinical Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 3.6 The Global POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.1 The POC Diagnostics Market: Shares (%) by Segments, 2016
  • Figure 4.2 World POC Diagnostics Market Forecast: Revenues ($bn), by Segment, 2016-2027
  • Figure 4.3 Scope of The POC Diagnostics Market: Revenue ($bn) and CAGR (%), by Segments, 2016
  • Figure 4.4 Global POC Diagnostics Market Forecast, By Product: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.5 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2016
  • Figure 4.6 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2021
  • Figure 4.7 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2027
  • Figure 5.1 The Global POC Blood Glucose Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.2 Market Shares (%) of Fingerstick Testing and CGM Devices in the POC Blood Glucose Monitoring Market, 2016
  • Figure 5.3 Market Shares (%) of Devices, Test Strips and Other Devices in the POC Blood Glucose Testing Market, 2016
  • Figure 5.4 Market Shares (%) of Leading National Markets in the POC Blood Glucose Testing Market, 2016
  • Figure 5.5 POC Blood Glucose Testing Market: Drivers and Restraints 2017-2027
  • Figure 6.1 The PT/INR POC Testing Market by Point of Use, Market Share (%), 2016
  • Figure 6.2 The POC Diagnostics Market: Shares (%) by Segments, 2016
  • Figure 6.3 The Global POC Coagulation Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 6.4 POC Coagulation Testing Market: Drivers and Restraints 2017-2027
  • Figure 7.1 Global Cardiac Marker Diagnostic Testing Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 7.2 Cardiac Marker Diagnostic Testing Market: Drivers and Restraints, 2017-2027
  • Figure 8.1 The POC Diagnostics Market: Shares (%) by Segments, 2016
  • Figure 8.2 Global POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), 2016-2027
  • Figure 8.3 POC Infectious Diseases Testing Market: Drivers and Restraints, 2016-2027
  • Figure 9.1 Global POC Pregnancy Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 9.2 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 10.1 POC Cholesterol Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 10.2 The POC Cholesterol Testing Market: Drivers and Restraints, 2016-2027
  • Figure 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn), 2016
  • Figure 11.2 Global POC Diagnostics Market, By Region: Revenues ($bn), 2017
  • Figure 11.3 Global POC Diagnostics Market, By Region: Revenue ($bn), 2016-2027
  • Figure 11.4 Global POC Diagnostics Market, By Region: Market Shares (%), 2016
  • Figure 11.5 Global POC Diagnostics Market, By Region: Market Shares (%), 2021
  • Figure 11.6 Global POC Diagnostics Market, By Region: Market Shares (%), 2027
  • Figure 11.7 US POC Diagnostics Market: Drivers and Restraints, 2016-2027
  • Figure 11.8 U.S. POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.9 European POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.10 European POC Diagnostics Market: Market Shares (%) by National Market, 2016
  • Figure 11.11 European POC Diagnostics Market: Market Shares (%) by National Market, 2021
  • Figure 11.12 European POC Diagnostics Market: Market Shares (%) by National Market, 2027
  • Figure 11.13 German POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.14 UK POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.15 French POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.16 Spanish POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.17 Italian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.18 The Netherlands POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.19 Belgian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.20 Swiss POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.21 Japanese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.22 BRICS POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.23 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2016
  • Figure 11.24 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2022
  • Figure 11.25 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2027
  • Figure 11.26 Chinese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.27 Indian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.28 Brazilian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.29 Russian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.30 South African POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 11.31 RoW POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 12.1 Roche: Diagnostics Revenue ($bn) and AGR (%), 2016-2027
  • Figure 12.2 Abbott: POC Diagnostics Revenue ($bn) and AGR (%), 2016-2027
  • Figure 12.3 Siemens Healthineers: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 12.4 Alere Inc. Revenue Shares (%), by Business Segment, 2016
  • Figure 12.5 Alere Professional Diagnostics Segment: Revenue Shares (%), by Group, 2016
  • Figure 12.6 Alere Inc.: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 13.1 POC Diagnostics Market: Drivers and Restraints 2017-2027
  • Figure 13.2 Porter's Five Forces Analysis of the POC Diagnostics Market, 2017-2027

List of Tables

  • Table 1.1 POC Diagnostics Market Forecast, By Product Revenue ($bn), AGR (%), CAGR (%), 2017-2027
  • Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017
  • Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued)
  • Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued)
  • Table 2.2 Advantages and Disadvantages of POC Diagnostics, 2017
  • Table 3.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016
  • Table 3.2 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 3.3 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Segments, 2016-2027
  • Table 3.4 The Clinical Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 3.5 The POC Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%),2016-2027
  • Table 4.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Type of Delivery, 2016
  • Table 4.2 The POC Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016
  • Table 4.3 Global POC Diagnostics Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Segment, 2016-2027
  • Table 5.1 Global Blood Glucose Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 5.2 POC Blood Glucose Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 5.3 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Type of Meter, 2016
  • Table 5.4 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Components, 2016
  • Table 5.5 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (A), 2016
  • Table 5.6 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (B-F), 2016
  • Table 5.7 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (F-N), 2016
  • Table 5.8 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (N-T), 2016
  • Table 5.9 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (T-Z), 2016
  • Table 5.10 Leading National Markets for the POC Blood Glucose Testing Market, Revenue ($bn) and Shares (%),2016
  • Table 5.11 Diabetes Care Business Segment, Revenue ($bn) and Shares (%), by Leading Companies, 2016
  • Table 5.12 List of Some Other Companies in the POC Blood Glucose Testing Market, 2016
  • Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016
  • Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016 (continued)
  • Table 6.1 Global Rapid Coagulation Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 6.2 List of Some Products in the POC Coagulation Testing Market for Self Testing and Professional Testing, 2016
  • Table 6.3 The PT/INR POC Testing Market, Revenue ($bn) and Shares (%), by Point of Use, 2016
  • Table 6.4 The Price of Some PT/INR POC Testing Systems ($), 2016
  • Table 6.5 The PT/INR POC Testing Market, Revenue ($m) and Shares (%), by Components, 2016
  • Table 6.6 POC Rapid Coagulation Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 7.1 Global Cardiac Marker Diagnostic Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 7.2 Time to Elevation for Some Cardiac Markers, 2016
  • Table 7.3 Clinical Use of the Cardiac Biomarkers, 2017
  • Table 7.4 POC Rapid Cardiac Marker Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 7.5 Leading Products in the Cardiac Marker Diagnostic Testing Market, by Company, 2016
  • Table 8.1 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 8.2 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 8.3 Strengths and Limitations of Some Leading Products in the HIV Rapid Testing Market, 2016
  • Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017
  • Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017 (continued)
  • Table 8.5 HIV RDTs For Self-Testing In The Pipeline, 2017
  • Table 8.6 List of Some Products in the POC Hepatitis Testing Market, 2016
  • Table 8.7 List of Some Products in the Rapid Influenza Testing Market, 2016
  • Table 8.8 POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 9.1 Global POC Pregnancy Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 9.2 POC Pregnancy Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 10.1 Global POC Cholesterol Testing Market, Revenue ($bn) and Share (%), 2016
  • Table 10.2 POC Cholesterol Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn) and Market Share (%) 2016 and 2017
  • Table 11.2 Global POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.3 U.S. POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 (continued)
  • Table 11.5 German POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.6 UK POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.7 French POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.8 Spanish POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.9 Italian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.10 The Netherlands POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.11 Belgian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.12 Swiss POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.13 Japanese POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.14 BRICS POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.15 China POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.16 Indian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.17 Brazilian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.18 Russian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.19 South African POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 11.20 RoW POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 12.1 F. Hoffmann-La Roche AG: Overview, 2017
  • Table 12.2 Roche Diagnostics: Key Product Launches Planned for 2017
  • Table 12.3 Roche Diagnostics: Revenue ($m) and Revenue Share (%), by Business Area, 2016
  • Table 12.4 Roche Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 12.5 Abbott: Overview, 2017
  • Table 12.6 Abbott Diagnostics: Business Highlights, 2016
  • Table 12.7 Abbott Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 12.8 Siemens Healthineers: Overview, 2017
  • Table 12.9 Siemens Healthineers POC Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 12.10 Alere Inc.: Overview, 2017
  • Table 12.11 Alere Inc.: Product Portfolio (Cardiometabolic), 2017
  • Table 12.12 Alere Inc.: Product Portfolio (Cardiometabolic, Infectious Diseases), 2017
  • Table 12.13 Alere Inc.: Product Portfolio (Infectious Diseases), 2017
  • Table 12.14 Alere Inc.: Product Portfolio (Infectious Diseases cont.) 2017
  • Table 12.15 Alere Inc.: Product Portfolio (Toxicology), 2017
  • Table 12.16 Alere Inc.: Revenue ($bn) and Change (%), by Business Area, 2015 & 2016
  • Table 12.17 Alere Inc. Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 13.1 POC Diagnostics Market: SWOT Analysis, 2017-2027

Companies Listed

  • 3M
  • Abaxis
  • Abaxis Inc
  • Abbott Cardiovascular Inc
  • Abbott Diabetes Care
  • Abbott Molecular Inc.
  • Abbott Point of Care
  • Abbott S.r.l.
  • Abbott SA
  • Advanced Care
  • Affymetrix, Inc.
  • AgaMatrix
  • Agendia BV
  • Alere Health Systems Inc.
  • Alere Medical Japan
  • Amgenix International Inc
  • Arkay
  • Ascensia Diabetes Care
  • Astra Zeneca
  • AutoGenomics, Inc.
  • Avioq, Inc.
  • B Braun
  • Bayer
  • BBI Helathcare
  • Becton Dickinson
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Biofire Diagnostics
  • BioLytical Laboratories
  • Bionime
  • Bio-Rad Laboratories
  • Biosense Medical
  • BioSign
  • Biosite Diagnostics
  • Biosynex Medtech
  • Boehringer Ingelheim
  • Calypte Biomedical
  • Celera Diagnostics
  • Cepheid
  • Cerus Corporation
  • Chembio Diagnostic Systems
  • Cholestech
  • Church & Dwight
  • Clinical Micro Sensors, Inc.
  • Concateno
  • Core Diagnostics
  • CVS/Pharmacy
  • Dako Denmark A/S
  • DakoCytomation Denmark A/S
  • Dario Health
  • Decision Diagnostics Corp.
  • Dexcom
  • Diabetic Supply of Suncoast
  • Diagnostic Devices
  • DiME
  • Early Pregnancy Tests.com
  • EKF Diagnostics
  • Entra Helath Systems
  • Exact Sciences Corporation
  • EY Laboratories
  • Fenwal Inc
  • Fifty50 Medical
  • Focus Diagnostics
  • ForaCare
  • Fujirebio
  • Genentech
  • General Life Biotechnology Ltd
  • Genesis Health Technology
  • GenMark Diagnostics
  • Gen-Probe, Inc.
  • Genzyme
  • Gluco Com
  • Grove Instruments
  • Halifax
  • Helena Laboratories
  • Hema technologies
  • Hologic, Inc.
  • Home Access Health Corporation
  • Horiba
  • IHelath Labs
  • Illumina, Inc.
  • IME-DC
  • IND Diagnostic Inc.
  • Infopia
  • Insight Pharmaceuticals
  • Instrumentation Laboratory (a company of Werfen Group)
  • InTec Products
  • Integrity Applications Ltd.
  • International Technidyne Corporation
  • Inverness Medical
  • Iris Molecular Diagnostics
  • JANT Pharmacal Corporation
  • Johnson & Johnson
  • LifeScan
  • Livongo Health
  • Luminex Molecular Diagnostics, Inc.
  • Marnes La Coquette
  • Maxim Biomedical Inc
  • Medford
  • Medix Biochemica
  • Medor
  • Menarini
  • Meridian Bioscience
  • Mitsubishi Chemical
  • MIZUHO MEDY Company
  • Myriad Genetic Laboratories, Inc.
  • Nani Daman
  • Nanosphere, Inc.
  • Nanostring Technologies
  • Nipro Diadnostics
  • Nova Diabetes
  • Oak Tree Health
  • Oak Tree International Holdings
  • Omnis Health
  • One Drop
  • OraSure Technologies
  • Orgenics
  • OrSense NBM-200G
  • Ortho-Clinical Diagnostics, Inc.
  • Osmetech Molecular Diagnostics
  • ParagonDx, LLC
  • Partec
  • Pathwork Diagnostics Inc.
  • Pharma Tech Solutions
  • Philosys
  • POC Medical System
  • PointCare Technologies
  • Polymer Technology Systems Inc
  • Premier Medical Corporation
  • Princeton Biomedtech
  • Procter & Gamble
  • Prodigy Diabetes Care
  • Proteome Systems
  • Quest Diagnostics
  • Quidel
  • Remel/Thermofisher
  • Response Biomedical Corporation
  • Roche Diagnostics Corporation
  • Roche Molecular Systems, Inc.
  • RunBio Biotech Company
  • SA Scientific
  • Sanofi
  • Savyon Diagnostics
  • Sedia Biosciences Corporation, USA
  • Sekisui Medical Company
  • Shanghai Kehua Bioengineering Co., Ltd.
  • Siemens Financial Services GmbH
  • Siemens Healthcare Diagnostics GmbH
  • Siemens Healthcare Diagnostics SA
  • Siemens Healthcare EOOD
  • Siemens Healthineers
  • Spartan Bioscience, Inc.
  • Spirit Healthcare
  • Standard Diagnostics Inc.
  • Swiss Precision Diagnostics
  • Symphony
  • Sysmex
  • Target
  • Telcare
  • Thermo Fisher Scientific
  • Third Wave Technologies Inc.
  • Tm Bioscience Corporation
  • TrimGen Corporation
  • Trinity Biotech
  • Trividia Health
  • Trovagene
  • U.S. Diagnostics
  • Unimed International
  • Universal Biosensors
  • Universal Diagnostics
  • Ventana Medical Systems, Inc.
  • Veridex, LLC.
  • Vysis
  • Walgreens
  • Walmart
  • WellDoc Corporation
  • xDx Inc.
  • YD Diagnostics
  • Ypsomed

List of Organizations

  • American Diabetes Association
  • Anti Coagulation Self-Monitoring Alliance
  • Atrial Fibrillation Association
  • Bill & Melinda Gates Foundation
  • Cancer Research UK
  • Children's Heart Federation
  • College of American Pathologists
  • Diabetes Research Unit Cymru
  • European Diagnostics Manufacturers Association
  • European Heart Network
  • Federal Joint Committee - Gemeinsamer Bundesausschuss
  • Food Drug and Administration
  • German Federal Ministry of Health
  • International Diabetes Federation
  • Internet Stroke Center
  • King's College London
  • MATCH Group
  • Mechanical Heart Valve Support Group
  • Ministry of Health, Labor and Welfare
  • National Health and Medical Research Council
  • National Health Services
  • Swansea University, UK
  • The National Institute for Health and Clinical Excellence
  • The PATH's Diagnostics Group
  • U.S. Centers for Medicare & Medicaid Services
  • UNITAID
  • Universidad Peruana Cayetano Heredia
  • University of California
  • US Preventative Services Task Force
  • World Health Organization
Back to Top